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We report three fatal cases of bacteremia (two adults, one neonate) caused
by Vibrio cholerae O1 (Ogawa), which occurred in the context of a commu-
nity outbreak of cholera diarrhea in Blantyre, Malawi. Only four cases of
invasive disease caused by V. cholerae O1 have previously been reported.
We describe the clinical features associated with these rare cases and dis-
cuss their significance.
Vibrio cholerae O1 and O139, the causative agents of
cholera, are morphologically and biochemically identical to
the other non-O1  V. cholerae, but antigenically, epi-
demiologically, and clinically distinct. Non-O1  V. cholerae
can cause small outbreaks of diarrheal illness related to con-
taminated seafood. There are, however, numerous case
reports of bacteremia caused by non-O1 V. cholerae in per-
sons with predisposing conditions, most commonly cirrhosis
(1) but also nephrotic syndrome, diabetes, hematologic
malignancy, gastrectomy, and AIDS/lymphoma (2). 
V. cholerae O1 and O139, by contrast, cause epidemic
diarrheal disease. V. cholerae O1, in particular, is reputed to
be noninvasive. Only three cases of bacteremia and one case
of meningitis caused by V. cholerae O1 have been reported,
from Australia (3), southern Africa (4), Pakistan (5), and
Mexico (6) (Table). We report a series of three cases of bacte-
remia caused by V. cholerae O1 from a single center in sub-
Saharan Africa (Queen Elizabeth Central Hospital [QECH],
Blantyre, Malawi), which occurred in the context of a com-
munity outbreak of cholera.
Cholera Outbreak
The three cases of bacteremia occurred during and after
a cholera outbreak in Blantyre, Malawi, during March 1998,
in which 178 adults (ages 15 to 68 years), 64 children (aged 1
month to 14 years), and 2 neonates were admitted to QECH
with cholera diarrhea. Case 1 (neonate) occurred during the
outbreak in March, and Cases 2 and 3 (adults) were among
the sporadic cases at QECH during the following 12 months.
The first cases in the outbreak were identified by stool
culture; thereafter, stool cultures were systematically
obtained for 1 in 10 of suspected cases, to monitor the out-
break. Median intravenous fluid requirement for adult cases
was 11 L (range 2 to 36). A single dose of doxycycline was
prescribed for all suspected cases. There were two adult and
two pediatric deaths during the March outbreak (overall
death rate 1.6%), including Case 1 with cholera bacteremia.
The three deaths not described below were attributed to
acute severe dehydration, and one was associated with sec-
ond-trimester abortion. During March 1998, adult patients
were admitted and nursed adjacent to the wards in a cholera
tent, where blood cultures were not routinely performed.
After March 1998, sporadic cases (including Cases 2 and 3)
continued to come to QECH; these patients were admitted to
the general medical wards of the hospital. Blood cultures
were routinely obtained for patients with fever and shock;




A male twin was born in QECH in March 1998, at 34
weeks’ gestation, by spontaneous vaginal delivery; he was
breastfed. He was well until day 2, when he became hypo-
thermic, hypoglycemic, and peripherally cyanosed. He had
no diarrhea. Blood culture was taken, treatment with peni-
cillin and gentamicin was begun, and expressed breast milk
was fed by nasogastric tube, but the child died 13 hours
later. Blood culture grew V. cholerae O1 at 24 hours (cloudy
bottle). A stool culture was not taken.
The second twin followed a similar clinical course and
died on day 2. Blood culture was negative. The mother was a
healthy 21-year-old, with no diarrheal disease. We were
unable to recall her for stool culture.
Case 2 (Adult) 
A previously healthy 45-year-old woman was admitted
to QECH in September 1998 with profuse, watery diarrhea.
She was afebrile, dehydrated, and tachycardic with thready
pulses, and was managed with 11 L of intravenous Ringer’s
lactate followed by oral rehydration therapy (ORT). Her
diarrhea became bloody, blood culture was taken, and nalid-
ixic acid was given empirically. Over 36 hours her diarrhea
resolved, her clinical state improved, and she was able to
move around, but she died suddenly on day 4 after an
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unwitnessed collapse. V. cholerae O1 was grown at 24 hours
(cloudy bottle). Stool culture had not been taken. 
Case 3 (Adult)
A previously healthy 65-year-old woman initially visited
an outlying rural health center in February 1999 with sud-
den onset of profuse watery diarrhea. She was treated with
35 L of intravenous fluid followed by ORT for 4 days. She
was not given antibiotics, her diarrhea ceased, and she was
discharged. The water supply in her village was a covered
well, and there was one simultaneous case of cholera diar-
rhea in the area, in a young woman, who fully recovered.
Over the next 3 days, Patient 3 had anuria, confusion,
and shivering but no further diarrhea. She was taken to
QECH, and on admission was afebrile, in shock, dehydrated,
and confused. A clinical assessment of dehydration and sep-
sis prompted empiric management with intravenous rehy-
dration, chloramphenicol, and gentamicin.
Blood tests revealed a leukocyte count of 22 x 109/L (88%
neutrophils), Na+ 173 mmol/L (normal 135-145), K + 3.8
mmol/L (normal 3.5-5.0), and urea 71 mg/dL (normal 8-25).
Liver function tests, urine examination, and chest X ray were
normal. V. cholerae O1 was grown from blood at 36-48 hours
(routine subculture) and was found to be sensitive to erythro-
mycin but resistant to ampicillin, chloramphenicol, cotrimox-
azole, and tetracycline; antibiotic therapy was changed
accordingly. Blood culture taken after 7 days of treatment
with erythromycin was negative. Rectal swab and urine cul-
tures were negative. HIV serologic testing was negative.
Despite rehydration and good subsequent urine output, she
remained in renal failure with presumed acute tubular
necrosis secondary to inadequate rehydration during her
original diarrheal illness. She died 14 days after admission.
Genomic Analysis
For adults, 5 mL of venous blood was incubated in a sin-
gle aerobic culture bottle of 50 mL brain heart infusion broth
containing sodium polyanetholesulphonate (E&O Laborato-
ries, United Kingdom) at 37°C in air. For neonates, 2 mL of
blood was incubated in 20 mL of broth in the same manner.
Routine blinded subcultures on sheep blood agar incubated
in CO2 were performed at 24 and 48 hours and at 7 days.
Bottles appearing cloudy were examined by Gram stain and
then subcultured onto appropriate media, dependent on
Gram stain findings. Antibiotic susceptibility testing was
performed by disk diffusion. The organisms were identified
biochemically and serologically as V. cholerae O1 (Ogawa). 
Blood culture isolates from Cases 1 and 3 were available
for subsequent genomic analysis. 16S rRNA sequence analy-
sis was performed by using universal oligonucleotide prim-
ers (7). The 1,500-bp product was extracted from the gel and
sequenced on an ABI PRISM system (Applied Biosystems,
Perkin Elmer Corp, Foster City, CA). The 16S sequence was
submitted to GenBank-BLAST Search for analysis. Multi-
plex polymerase chain reaction (PCR) was used to determine
the presence of important virulence factors, namely, cholera
toxin (ctx), toxin-regulated pilus (tcp), and the global regula-
tory element toxR, as described (8). Plasmids were extracted
from control (Escherichia coli 39R861, E. coli V517) and test
bacteria (Plasmid mini kit, Quiagen Ltd., Germany) and sep-
arated by electrophoresis. Pulsed-field gel electrophoresis
(PFGE) of chromosomal DNA following digestion with the
restriction endonuclease Spe1 was performed. Clonal relat-
edness of the cholera isolates was assessed according to the
criteria of Tenover (9).
16S rRNA sequence analysis confirmed both isolates as
V. cholerae. Multiplex PCR amplicons of the appropriate size
were detected for ctxA (301 bp), tcpA (618 bp), and toxR (900
bp). No plasmids were detected from the test isolates (the
upper limit of plasmid size detection was 160 kbp). The two
isolates were indistinguishable by PFGE of macrorestricted
chromosomal DNA.
Conclusions
This is the first reported series of V. cholerae O1 bacter-
emic cases. Biochemical, serologic, and genomic analysis con-
firmed the identity of the organisms as  V. cholerae O1
(Ogawa).
These isolates could have been contaminants, arising on
the ward or in the laboratory. Several features, however,
make this unlikely. Skin was disinfected before blood was
taken from the antecubital fossa, and a pure growth without
skin contaminants was obtained in all three cases after 24 to
48 hours. Cases 2 and 3 postdated the main cholera out-
break, so the patients were not in a cholera tent and samples
were not taken in an epidemic situation. There were no other
coincident cases of cholera on the ward at the time. More-
over, in Case 3 a rectal swab culture was negative at patient
Table. All reported cases of invasive disease caused by Vibrio cholerae O1, in chronological order
Age, sex  Susceptibility  Clinical features  Outcome  Ref
6 years, female  Autoimmune disease, 
achlorhydria 
Diarrhea, severe sepsis syndrome  Survived after intensive therapy  3
6 days, male  Neonate  Diarrhea, afebrile, neutrophilia, 
uremia 
Died   4
8 months, female  None  Diarrhea, febrile, neutrophilia Survived with rehydration and 
antibiotics 
5
6 years, female  Chemotherapy  Meningitis, blood culture negative  Died  6
2 days, male  Neonate  No diarrhea  Died  TR
45 years, female None  Diarrhea transiently bloody, afebrile  Died  TR
65 years, female  None  Diarrhea, neutrophilia, renal failure 
secondary to dehydration 
Died of renal failure after 2-3 
weeks 
TR
TR = this report; see text.Dispatches
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admission, and the blood culture sample was taken in the
general medical admissions area before the patient was
transferred to the diarrhea bay. The blood culture specimens
were handled in a research laboratory, in a separate building
from the government laboratory where all stool cultures
were performed. The three isolates could not be linked to any
single technician or ward nurse, nor were they clustered in
time. Finally, the high case death rate compared with the
1.6% overall death rate suggests that the isolates were of
clinical relevance. Previously reported cases also show a poor
outcome (Table). 
Why did we observe bacteremia? All the cases we
describe had unusual features or complications. Case 1 had
no diarrheal illness, Case 2 had transient bloody diarrhea,
and Case 3 was in an elderly woman who had renal failure
secondary to inadequate initial rehydration. Invasive
V.cholerae O1 disease has been associated with autoimmune
disease, achlorhydria, and chemotherapy in two of the four
previously reported cases (3,6), but our adult patients did
not have known longstanding immunosuppression. HIV dis-
ease is common in Blantyre and is associated with bactere-
mia caused by Streptococcus pneumoniae and nontyphoid
salmonellae (10), but no reports link HIV with severe or
invasive V. cholerae O1 infections. V. cholerae O1 was grown
from the stool of 5 of 77 Guatemalan AIDS patients; none
had a fatal outcome, and 4 had only mild diarrhea. Three of
these cases had enteric coinfection with Cryptosporidium or
nontyphoid Salmonella (11).
Case 2 had transient bloody diarrhea, unlikely to be
caused by V. cholerae alone. It is noteworthy that V. cholerae
(unknown serogroup) and  Salmonella enterica  serotype
Typhi  were simultaneously isolated from blood in a 1932
case (12). Enteric bacterial coinfection may have facilitated
mucosal invasion by V. cholerae in both these cases.
Cholera is well described in children <2 years of age,
and breast feeding is protective (13). Cholera diarrhea is,
however, extremely rare in neonates. (We found two cases
with positive stool cultures during this outbreak.) Colostrum
may offer potent protection among breastfed neonates in dis-
ease-endemic areas, mediated by specific immunoglobulin
(Ig) A (14). Despite breastfeeding, however, Case 1 may have
acquired V. cholerae O1 infection during birth from a mother
with asymptomatic stool carriage (common during an out-
break). The early events of infection or invasion could have
occurred before the first colostrum feed; the onset of symp-
toms on day 2 of life would be in keeping with this. The pre-
viously reported neonatal case (4) also had a healthy mother
and onset of symptoms on day 5 of life.
The true incidence of bacteremia during this outbreak is
unknown, as blood cultures were not routinely taken in the
cholera tents. While V. cholerae O1 bacteremia is apparently
a rare event, reported cases suggest that persons at risk
include those with underlying immunosuppression (chemo-
therapy, autoimmune disease, achlorhydria), the elderly,
and neonates. Enteric bacterial coinfection may play a role
in invasion. There is no evidence that HIV infection is a risk
factor. Intravenous rehydration and ORT remain the main-
stays of successful treatment, but our experience reempha-
sizes the importance of antibiotics as adjunctive treatment.
What could be the route of invasion of V. cholerae O1?
Intestinal M cells are enterocytes adapted to sample enteric
organisms, which are then translocated to gut lymphoid tis-
sue, where a specific sIgA response is generated. Viable
V.cholerae O1 organisms are translocated across the mucosa
in this manner by M cells. This has been proposed as the
route by which  V. cholerae O1 may in some circumstances
cause bacteremic illness (15).
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